Ultrasound-guided Intermediate Cervical Plexus Block
- Conditions
- Internal Carotid Artery Stenosis
- Interventions
- Other: cervical plexus blockOther: facial nerve blockOther: perivascular block
- Registration Number
- NCT02794974
- Lead Sponsor
- Helios Research Center
- Brief Summary
The investigators test with the present study design, whether an ultrasound-guided blockade of the cervical plexus in combination with an additional application of local anesthetic to the superficial cervical ansa (facial nerve: cervical branch) leads to an improved quality of anesthesia.
- Detailed Description
The innervation of the neck area is complex and includes cranial nerve (innervation of the vessel wall (IX,X) and of the neck muscles (VII,XI)), as well as the cervical plexus and brachial plexus. This is a major cause of insufficient anesthesia quality during carotid endarterectomies.
The investigators test with the present prospective study design, whether an ultrasound-guided blockade of the cervical plexus in combination with an additional application of local anesthetic to the superficial cervical ansa (facial nerve: cervical branch) leads to an improved quality of anesthesia.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 29
- internal carotid stenosis: open surgical revascularization
- age over 18 years
- written informed consent
- allergy (local anesthetics)
- pregnancy
- participation in other studies
- drug addiction
- non-cooperative patients
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description with perivascular block facial nerve block 1. ultrasound-guided intermediate cervical plexus block (20ml ropivacaine 0.75%) 2. facial nerve block (cervical branch) (5ml prilocaine 1%) 3. perivascular block (5ml prilocaine 1%) without perivascular block cervical plexus block 1. ultrasound-guided intermediate cervical plexus block (20ml ropivacaine 0.75%) 2. facial nerve block (cervical branch) (5ml prilocaine 1%) with perivascular block cervical plexus block 1. ultrasound-guided intermediate cervical plexus block (20ml ropivacaine 0.75%) 2. facial nerve block (cervical branch) (5ml prilocaine 1%) 3. perivascular block (5ml prilocaine 1%) with perivascular block perivascular block 1. ultrasound-guided intermediate cervical plexus block (20ml ropivacaine 0.75%) 2. facial nerve block (cervical branch) (5ml prilocaine 1%) 3. perivascular block (5ml prilocaine 1%) without perivascular block facial nerve block 1. ultrasound-guided intermediate cervical plexus block (20ml ropivacaine 0.75%) 2. facial nerve block (cervical branch) (5ml prilocaine 1%)
- Primary Outcome Measures
Name Time Method Local Anesthetic Supplementation (Frequency) intraoperatively number of participants who need supplementation of prilocaine 1% by the surgeon (%)
Local Anesthetic Supplementation (Volume) intraoperatively volume of prilocaine 1% supplemented by the surgeon (ml)
- Secondary Outcome Measures
Name Time Method Cough intraoperatively number of participants who experienced side effects: cough
Dysphagia intraoperatively number of participants who experienced side effects: dysphagia
Hoarseness intraoperatively number of participants who experienced side effects: hoarseness
Trial Locations
- Locations (1)
Helios Medical Center Schwerin, Department of Anaesthesiology and Intensive Care
🇩🇪Schwerin, Mecklenburg-Vorpommern, Germany